Using artificial intelligence to predict patient outcomes from patient-reported outcome measures: a scoping review
- PMID: 40217230
- PMCID: PMC11987430
- DOI: 10.1186/s12955-025-02365-z
Using artificial intelligence to predict patient outcomes from patient-reported outcome measures: a scoping review
Abstract
Purpose: This scoping review aims to identify and summarise artificial intelligence (AI) methods applied to patient-reported outcome measures (PROMs) for prediction of patient outcomes, such as survival, quality of life, or treatment decisions.
Introduction: AI models have been successfully applied to predict outcomes for patients using mainly clinically focused data. However, systematic guidance for utilising AI and PROMs for patient outcome predictions is lacking. This leads to inconsistency of model development and evaluation, limited practical implications, and poor translation to clinical practice.
Materials and methods: This review was conducted across Web of Science, IEEE Xplore, ACM, Digital Library, Cochrane Central Register of Controlled Trials, Medline and Embase databases. Adapted search terms identified published research using AI models with patient-reported data for outcome predictions. Papers using PROMs data as input variables in AI models for prediction of patient outcomes were included.
Results: Three thousand and seventy-seven records were screened, 94 of which were included in the analysis. AI models applied to PROMs data for outcome predictions are most commonly used in orthopaedics and oncology. Poor reporting of model hyperparameters and inconsistent techniques of handling class imbalance and missingness in data were found. The absence of external model validation, participants' ethnicity information and stakeholders involvement was common.
Conclusion: The results highlight inconsistencies in conducting and reporting of AI research involving PROMs in patients' outcomes predictions, which reduces the reproducibility of the studies. Recommendations for external validation and stakeholders' involvement are given to increase the opportunities for applying AI models in clinical practice.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Competing interests: Galina Velikova: Honoraria: Pfizer, Novartis, Eisai, Lilly Advisory boards: Consultancy fees from AstraZeneca, Roche, Novartis, Pfizer, Seagen, Eisai, Sanofi April 2024 = AZ working group (unpaid) Institutional grant: Pfizer.
Figures





Similar articles
-
The role of patient-reported outcome measures in trials of artificial intelligence health technologies: a systematic evaluation of ClinicalTrials.gov records (1997-2022).Lancet Digit Health. 2023 Mar;5(3):e160-e167. doi: 10.1016/S2589-7500(22)00249-7. Lancet Digit Health. 2023. PMID: 36828608 Review.
-
Application of Artificial Intelligence in Community-Based Primary Health Care: Systematic Scoping Review and Critical Appraisal.J Med Internet Res. 2021 Sep 3;23(9):e29839. doi: 10.2196/29839. J Med Internet Res. 2021. PMID: 34477556 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Methodological and Quality Flaws in the Use of Artificial Intelligence in Mental Health Research: Systematic Review.JMIR Ment Health. 2023 Feb 2;10:e42045. doi: 10.2196/42045. JMIR Ment Health. 2023. PMID: 36729567 Free PMC article. Review.
-
Existing Barriers Faced by and Future Design Recommendations for Direct-to-Consumer Health Care Artificial Intelligence Apps: Scoping Review.J Med Internet Res. 2023 Dec 18;25:e50342. doi: 10.2196/50342. J Med Internet Res. 2023. PMID: 38109173 Free PMC article.
References
-
- P. Rajpurkar, J. Yang, N. Dass, V. Vale, A.S. Keller, J. Irvin, and L.M. Williams Evaluation of a machine learning model based on pretreatment symptoms and electroencephalographic features to predict outcomes of antidepressant treatment in adults with depression: a prespecified secondary analysis of a randomized clinical trial. JAMA network open, 3(6),e206653-e206653. 2020 - PMC - PubMed
-
- D. Verma, K. Bach, and P. J. Mork, “Application of Machine Learning Methods on Patient Reported Outcome Measurements for Predicting Outcomes: A Literature Review,” Informatics, vol. 8, p. 56, 2021. Number: 3 Publisher: Multidisciplinary Digital Publishing Institute.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources